( OTCQB: BIXT) today announced positive clinical results from its recently completed Phase 2 randomized, double-blind, ...

RWD and RWE are reshaping the design of clinical trials, making them smarter, faster, and more efficient. Read more here: ...

Welcome to the Viking Therapeutics Fourth Quarter and Full Year 2025 Financial Results Conference Call. [Operator ...

The Wall Street Journal editorial board published a scathing takedown on Wednesday of President Donald Trump's top Food and ...

Most return-to-office mandates aren’t solving a collaboration problem. They’re solving an assessment problem that physical ...

FDA proposes MRD-negative and complete response endpoints to fast-track multiple myeloma drug approvals, pushing deeper molecular results over ORR.

February 2026 is shaping up to be a monumental month for Xbox enthusiasts, with a diverse slate of titles arriving on both ...

Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...

By Dr. Sanchari Sinha Dutta, Ph.D. A randomized trial suggests that avoiding coffee after cardioversion may not help, and that modest caffeine intake may actually be associated with fewer atrial ...

This engagement begins as a defined pilot, with a clear path to expand into a multi-study commercial relationship based on results. For Lunai, this is the kind of near-term work that can translate ...

Discusses Share Buyback Program, Financial Position, and Development Strategy for NNZ-2591 February 11, 2026 6:30 ...

Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease The Phase 2 study ...